Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Ebiomedicine
|
January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Ebiomedicine
|
August 1, 2022
Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Nature Communications
|
December 6, 2014
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Peijing Zhang, Li Wang, Cristian Rodriguez-Aguayo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 17, 2019
MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial Cells
Basak Icli, Winona Wu, Denizhan Ozdemir, et al.
Nucleic Acids Research
|
August 28, 2016
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
N Dinuka Abeydeera, Martin Egli, Nehemiah Cox, et al.
JCI Insight
|
October 26, 2016
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
Lingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
JCI Insight
|
April 1, 2021
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
Lingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
JCI Insight
|
June 12, 2018
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
Lingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
Cell Reports
|
April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer
Peijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Nature Communications
|
March 13, 2014
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity
Sherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Ebiomedicine
|
January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Ebiomedicine
|
August 1, 2022
Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304]
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Nature Communications
|
December 6, 2014
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Peijing Zhang, Li Wang, Cristian Rodriguez-Aguayo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 17, 2019
MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial Cells
Basak Icli, Winona Wu, Denizhan Ozdemir, et al.
Nucleic Acids Research
|
August 28, 2016
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
N Dinuka Abeydeera, Martin Egli, Nehemiah Cox, et al.
JCI Insight
|
October 26, 2016
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
Lingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
JCI Insight
|
April 1, 2021
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
Lingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
JCI Insight
|
June 12, 2018
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
Lingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
Cell Reports
|
April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer
Peijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Nature Communications
|
March 13, 2014
2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity
Sherry Y Wu, Xianbin Yang, Kshipra M Gharpure, et al.
Page
of 4